Chemomab Therapeutics Ltd.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2019 | — | — | $32.1M |
| Jun 2019 | — | — | $27.0M |
| Sep 2019 | — | — | $23.2M |
| Dec 2019 | $4.8M | $19.8M | $17.6M |
| Mar 2020 | $3.6M | $15.2M | $14.0M |
| Jun 2020 | $1.9M | $10.0M | $8.8M |
| Sep 2020 | $2.3M | $7.7M | $6.8M |
| Dec 2020 | $1.7M | $12.5M | $11.7M |
| Mar 2021 | $5.0M | $60.1M | $58.2M |
| Jun 2021 | $2.5M | $70.5M | $45.4M |
| Sep 2021 | $1.9M | $67.4M | $37.7M |
| Dec 2021 | $2.9M | $64.4M | $15.2M |
| Mar 2022 | $3.7M | $61.0M | $13.8M |
| Jun 2022 | $4.5M | $56.4M | $9.9M |
| Sep 2022 | $5.6M | $50.2M | $10.7M |
| Dec 2022 | $6.8M | $43.1M | $13.5M |
| Mar 2023 | $7.1M | $35.0M | $20.8M |